Clinical Trial Update: Intratracheal Budesonide/Surfactant Prevents BPD [Phase 4]

View source ↗

Summary

Phase 4 trial updating on intratracheal budesonide with surfactant for prevention of bronchopulmonary dysplasia in respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Respiratory Distress Syndrome

Drugs mentioned

• Budesonide with surfactant (budesonide)

Snippet

Sponsor: Taipei Medical University | Conditions: Respiratory Distress Syndrome, Bronchopulmonary Dysplasia | Phase 4 | Status: COMPLETED